NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD) for NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Rare Disease Initiatives. Affordable Care Act (ACA) Issues and Enhancements. H.R.6892: Medical Nutrition Equity Act of 2023. H.R.2940/S.1355: PASTEUR Act. March-in Rights.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MASON OLIVER BARRETT | — |
| HAYLEY DEMPSEY | — |
| HEIDI ROSS | — |
Medicare/Medicaid MMM
Medicare / Medicaid issues impacting patients with rare diseases. Inflation Reduction Act Implementation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MASON OLIVER BARRETT | — |
| HAYLEY DEMPSEY | — |
| KARIN HOELZER | — |
| HEIDI ROSS | — |
Pharmacy PHA
Pharmaceutical issues impacting patients with rare diseases. Orphan Drug Act. Prescription Drug User Fee Act (PDUFA) Reauthorization. H.R.7383/S.1214: RARE Act. Inflation Reduction Act Implementation. Rare Pediatric Disease Priority Review Vouchers (RDP-PRV). Pediatric Study Requirements. Promising Pathway Act (PPA). Lab-developed tests (LDTs) and genetic testing access.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MASON OLIVER BARRETT | — |
| HAYLEY DEMPSEY | — |
| KARIN HOELZER | — |
| HEIDI ROSS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.